We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Robert Regenhardt

Robert W. Regenhardt MD, PhD

Vascular Neurologist and Neuroendovascular Fellow, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts

Robert W. Regenhardt, MD, PhD, completed college and medical school through an early acceptance program at the University of Florida in his home state. As he developed further interests in research, he pursued combined MD-PhD training. His dissertation work involved exploring neuroprotective effects of angiotensin peptides in both ischemic stroke and intracerebral hemorrhage using preclinical models. He completed neurology residency and vascular neurology fellowship at Harvard Medical School’s Massachusetts General Hospital and Brigham and Women’s Hospital. He is currently a neuroendovascular fellow at Massachusetts General Hospital. His research interests span the spectrum of translation, from understanding white matter ischemia and repair after stroke to improving stroke care systems for patients in Boston and abroad.

Disclosures

Dr. Regenhardt has no relevant disclosures.